Comparison of human ocular distribution of bimatoprost and latanoprost
- PMID: 22136089
- DOI: 10.1089/jop.2011.0097
Comparison of human ocular distribution of bimatoprost and latanoprost
Abstract
Purpose: This study investigated the ocular distribution of bimatoprost, latanoprost, and their acid hydrolysis products in the aqueous humor, cornea, sclera, iris, and ciliary body of patients treated with a single topical dose of 0.03% bimatoprost or 0.005% latanoprost for understanding concentration-activity relationships.
Methods: Thirty-one patients undergoing enucleation for an intraocular tumor not affecting the anterior part of the globe were randomized to treatment with bimatoprost or latanoprost at 1, 3, 6 or 12 h prior to surgery. Concentrations of bimatoprost, bimatoprost acid, latanoprost, and latanoprost acid in the human aqueous and ocular tissues were measured using liquid chromatography tandem mass spectrometry.
Results: Following topical administration, intact bimatoprost was distributed in human eyes with a rank order of cornea/sclera >iris/ciliary body >aqueous humor. Bimatoprost acid was also detected in these tissues, where its low levels in the cornea relative to that of latanoprost acid indicated that bimatoprost hydrolysis was limited. Latanoprost behaved as a prodrug that entered eyes predominantly via the corneal route. Levels of latanoprost acid were distributed as cornea >>aqueous humor>iris>sclera>ciliary body.
Conclusions: Our study provided experimental evidence that levels of bimatoprost in relevant ocular tissues, and not only aqueous humor, are needed to understand the mechanisms by which bimatoprost lowers intraocular pressure (IOP) in human subjects. The data suggest that bimatoprost reached the target tissues favoring the conjunctival/scleral absorption route. Findings of intact bimatoprost in the target ciliary body indicated its direct involvement in reducing IOP. However, bimatoprost acid may have only a limited contribution on the basis that bimatoprost has greater/similar IOP-lowering efficacy than latanoprost, yet bimatoprost acid levels were a fraction of latanoprost acid levels in the aqueous humor and cornea and only sporadically detectable in the ciliary body. In this report, human ocular tissues were examined concurrently with aqueous humor for the in vivo distribution of bimatoprost, bimatoprost acid, latanoprost, and latanoprost acid.
Similar articles
-
Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.J Ocul Pharmacol Ther. 2010 Apr;26(2):147-56. doi: 10.1089/jop.2009.0098. J Ocul Pharmacol Ther. 2010. PMID: 20307216 Clinical Trial.
-
Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4571-7. doi: 10.1167/iovs.05-0723. Invest Ophthalmol Vis Sci. 2005. PMID: 16303950
-
Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract.Br J Ophthalmol. 2007 May;91(5):629-32. doi: 10.1136/bjo.2006.110155. Epub 2006 Nov 29. Br J Ophthalmol. 2007. PMID: 17135335 Free PMC article. Clinical Trial.
-
A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.Curr Med Res Opin. 2007 Mar;23(3):601-8. doi: 10.1185/030079907X178720. Curr Med Res Opin. 2007. PMID: 17355741 Review.
-
Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.Curr Med Res Opin. 2005 Nov;21(11):1875-83. doi: 10.1185/030079905X65600. Curr Med Res Opin. 2005. PMID: 16307709 Review.
Cited by
-
The Multifarious Effects of Various Glaucoma Pharmacotherapy on Corneal Endothelium: A Narrative Review.Ophthalmol Ther. 2023 Jun;12(3):1457-1478. doi: 10.1007/s40123-023-00699-9. Epub 2023 Mar 17. Ophthalmol Ther. 2023. PMID: 36930417 Free PMC article. Review.
-
Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.Thyroid. 2013 Dec;23(12):1600-8. doi: 10.1089/thy.2013.0194. Epub 2013 Nov 4. Thyroid. 2013. PMID: 24001049 Free PMC article.
-
Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes.Clin Ophthalmol. 2013;7:1549-56. doi: 10.2147/OPTH.S48766. Epub 2013 Jul 31. Clin Ophthalmol. 2013. PMID: 23940414 Free PMC article.
-
A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits.PLoS One. 2012;7(11):e50180. doi: 10.1371/journal.pone.0050180. Epub 2012 Nov 27. PLoS One. 2012. PMID: 23209668 Free PMC article.
-
Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues.J Ocul Pharmacol Ther. 2019 Jan/Feb;35(1):50-57. doi: 10.1089/jop.2018.0067. Epub 2018 Oct 18. J Ocul Pharmacol Ther. 2019. PMID: 30335560 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical